Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 9 | 2025 | 479 | 2.210 |
Why?
|
| Nanoparticles | 5 | 2025 | 232 | 1.910 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2093 | 1.070 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 237 | 0.910 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 49 | 0.660 |
Why?
|
| Prodrugs | 2 | 2020 | 59 | 0.660 |
Why?
|
| Coumarins | 2 | 2016 | 23 | 0.630 |
Why?
|
| Placenta | 4 | 2025 | 508 | 0.560 |
Why?
|
| Bibenzyls | 1 | 2016 | 1 | 0.510 |
Why?
|
| Naphthalenes | 1 | 2016 | 37 | 0.500 |
Why?
|
| Neoplasms | 3 | 2020 | 2780 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 3560 | 0.380 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1695 | 0.380 |
Why?
|
| Aorta | 2 | 2025 | 547 | 0.320 |
Why?
|
| Tubulin | 4 | 2020 | 103 | 0.320 |
Why?
|
| Animals | 13 | 2025 | 34235 | 0.270 |
Why?
|
| Particle Size | 1 | 2025 | 124 | 0.230 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 25 | 0.230 |
Why?
|
| Photons | 1 | 2025 | 48 | 0.230 |
Why?
|
| Mice | 10 | 2025 | 17645 | 0.220 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 799 | 0.220 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4396 | 0.200 |
Why?
|
| Placenta Accreta | 1 | 2025 | 157 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4406 | 0.190 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 31 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 85 | 0.170 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 64 | 0.170 |
Why?
|
| Amyloid | 1 | 2020 | 65 | 0.170 |
Why?
|
| Aortography | 1 | 2021 | 202 | 0.170 |
Why?
|
| Stilbenes | 1 | 2020 | 36 | 0.170 |
Why?
|
| Solubility | 2 | 2018 | 138 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2021 | 121 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 199 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2020 | 99 | 0.160 |
Why?
|
| Fluorine | 1 | 2018 | 15 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 56 | 0.150 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 330 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2016 | 564 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 581 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 556 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2015 | 11 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2020 | 675 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2016 | 67 | 0.120 |
Why?
|
| Water | 1 | 2016 | 186 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 151 | 0.120 |
Why?
|
| Breast | 1 | 2016 | 214 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 3344 | 0.110 |
Why?
|
| Benzocycloheptenes | 1 | 2013 | 1 | 0.110 |
Why?
|
| Amino Acids | 1 | 2016 | 666 | 0.100 |
Why?
|
| Humans | 8 | 2025 | 124705 | 0.080 |
Why?
|
| Pregnancy | 4 | 2025 | 7171 | 0.080 |
Why?
|
| Gadolinium | 2 | 2019 | 107 | 0.080 |
Why?
|
| Liposomes | 2 | 2019 | 188 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2509 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 94 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2397 | 0.060 |
Why?
|
| Polymerization | 2 | 2015 | 13 | 0.060 |
Why?
|
| Female | 6 | 2025 | 66577 | 0.060 |
Why?
|
| Male | 3 | 2025 | 61317 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1695 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 93 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2020 | 53 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 87 | 0.040 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2020 | 4 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 44 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 44 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 181 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 94 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 165 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 206 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 391 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 126 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 81 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 212 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 553 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 41 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 55 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 63 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 57 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 134 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1002 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3742 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 465 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 780 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2161 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 110 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2057 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3728 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 3083 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 295 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 6323 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2303 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 16263 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 29554 | 0.010 |
Why?
|